Accelus

ACCELUS LEADERSHIP

Chris Walsh,
Chief Executive Officer & Co-Founder

Chris Walsh has served as the Chief Executive Officer and Co-Founder of Accelus since 2016. From 2004 to 2013, Mr. Walsh distributed NuVasive for the state of Florida. Additionally, Mr. Walsh worked at Stryker Corporation as a Sales Manager from 1997 to 2004. Mr. Walsh holds a B.A. from the University of Florida.

Kevin McGann,
President

Kevin McGann has served as the President and Chief Commercial Officer of Accelus since 2020 and previously served as the Chief Commercial Officer of Integrity Implants Inc. from 2019 to 2020.  Prior to this, Mr. McGann served as the President and Chief Executive Officer of Kallista Partners, LLC from 2017 to 2019. Additionally, Mr. McGann served as the Vice President of Sales of Stryker Corporation from 2015 to 2017. Mr. McGann holds a B.S. in Business Administration from Villanova University.

Wyatt Geist,
Chief Innovation Officer & Co-Founder

Wyatt Geist has served as the Chief Innovation Officer of Accelus since it was established in 2021. Previously, Mr. Geist served as Chief Technology Officer & Co-Founder of Integrity Implants Inc. Mr. Geist started his career as  a chemist before moving into spinal implant distribution and ultimately focusing on product development and company formation. Mr. Geist has over 130 patent applications mostly dealing with medical implants and GPS location technologies.  He has also sold several technologies to large companies. Mr. Geist has served on the boards of SafeWire, Accelus, and GeoToll Inc. Mr. Geist holds a B.S. in Microbiology from Auburn University.

Kevin Williamson,
Chief Financial Officer

Kevin Williamson has served as the Chief Financial Officer of Accelus since 2020 and previously served as the Director of Finance of Integrity Implants Inc. from 2019 to 2020. From 2015 to 2019, Mr. Williamson held various roles in the Corporate Finance Department at NuVasive, Inc., a California-based medical device company, including serving as the Manager of Corporate Finance from 2018 to 2019. Mr. Williamson holds a B.S. in Business Administration, Finance from San Diego State University and an M.B.A. from the University of San Diego – Knauss School of Business.

Brad Clayton,
Chief Technical Officer

Brad Clayton has served as the Chief Technical Officer of Accelus since 2021. Mr. Clayton has served as the Chief Executive Officer of Practical Navigation, LLC since 2018 and previously served as the Chief Executive Officer of Fusion Robotics, LLC from 2019 to 2021. Additionally, Mr. Clayton served as the President of CAMERIC Medical, Inc. from 2017 to 2018 and the Global Director of Robotics for Medtronic Brain and Spine Therapies from 2015 to 2017. Mr. Clayton holds a B.S. in Mechanical Engineering and a B.S. in Chemical Engineering from the University of Nevada, Reno.

Blake Stone, Chief Administrative Officer & General Counsel

Blake Stone has served as the Chief Administrative Officer and General Counsel of Accelus since 2018. Mr. Stone has also served as the General Counsel of Spinal Elements (formerly Amendia, Inc.), a California-based manufacturer and distributor of spinal implants and related accessories, from 2017 to 2018 and as the Assistant General Counsel of Amendia, Inc. from 2013 to 2017. Mr. Stone holds an A.B. in Government from Harvard University and a J.D. from the University of Georgia School of Law.

Andrew Wolf,
Chief Strategy Officer

Andrew Wolf has served as the Chief Strategy Officer of Accelus since 2021. Prior to this, Mr. Wolf successively served as Integrity Implants Inc.’s Director of Product Development, Executive Vice President of Products, and Chief Operating Officer, beginning in 2017. Prior to joining Integrity Implants, Mr. Wolf served as a Senior Product Manager and Group Manager for NuVasive and as Junior Associate for Falcon Financial Partners. Mr. Wolf holds a B.S. in Finance from San Diego State University.

ACCELUS BOARD OF DIRECTORS

Alex Lukianov

Alexis V. Lukianov has served as the Chairman of the Accelus Board of Directors since 2021. Mr. Lukianov is the Chairman of DuraStat, LLC, a privately held surgical device company, since 2019 and is the co-founder, Chairman and Chief Executive Officer of Tissue Differentiation intelligence , LLC, a privately held ultrasound Artificial Intelligence spine company, since 2017. Additionally, Mr. Lukianov is the founder of NuVasive, Inc. and was the Chief Executive Officer from 1999 and both the Chairman and Chief Executive Officer from 2004 to 2015. Mr. Lukianov was a founder, and served as the Chairman and Chief Executive Officer, of BackCare Group, Inc. from 1996 to 1997 which was sold to Bass Brothers. Prior to this, Mr. Lukianov held a variety of senior executive positions, including President of Medtronic Sofamor Danek, Inc. and director of a business unit at Smith+Nephew that brought limb-lengthening technology to the United States and internationally outside Russia, and managed the artificial ligament program in a joint venture between Stryker Corporation and Meadox Medicals. Mr. Lukianov has served on the boards of directors of Volcano (acquired by Phillips), Orthofix Medical Inc., Systems Oncology and On Point Technology. Mr. Lukianov has also served as the Principal of Lukpartners, LLC since 2015 and is a prolific philanthropist in the arts and eastern orthodox seminary education, as well as an avid race car driver. He has earned multiple awards as an entrepreneur and business leader, and also earned a Tony as a Broadway producer for Best Musical and multi Grammy nominated artist and producer of choral music. Mr. Lukianov attended Rutgers University and served in the US Navy Hospital corps.  

Heather Ace

Heather Ace has served as a director of Accelus since 2022. Ms. Ace also presently serves as the Chair of Accelus’s Compensation Committee. Additionally, Ms. Ace has served as the Chief Human Resources Officer for Qualcomm since 2020 and served as the Chief Human Resources Officer for Dexcom, Inc. from 2016 to 2020. Ms. Ace also serves on the Executive Committee for Connect, a California-based nonprofit organization, and is a board member of the San Diego Regional Economic Development Corporation, a San Diego-based nonprofit economic development organization. Ms. Ace holds a B.A. in Law & Society from the University of California, Santa Barbara and a J.D. from Santa Clara University School of Law.

Ned Lipes

Ned Lipes has served as a director of Accelus since 2016. Mr. Lipes also presently serves as the Chair of Accelus’s Nominating and Corporate Governance Committee. Mr. Lipes served as the Group President of Stryker Corporation, a Michigan-based medical technologies corporation, from 1988 to 2003. Additionally, Mr. Lipes was previously chairman of the New Jersey Arthritis Foundation from 2000 to 2002 and served on the boards of directors of Old Palm Golf Club from 2008 to 2019, the Northern New Jersey Council of the Boy Scouts from 2003 to 2019 and the Leeds Foundation from 2014 to 2020. Mr. Lipes has served as the President of One Singer Island Condo Association since 2007. Mr. Lipes holds a B.A. in Administration Science from Colby College and an M.B.A. from Harvard Business School.

Joseph Swedish

Joseph R. Swedish has served as a director of Accelus since 2022. Mr. Swedish is a Co-Founder and Partner at Concord and a member of the Firm’s Investment Committee. Mr. Swedish has more than 45 years of healthcare leadership experience. Most recently, Mr. Swedish was Chairman, President & Chief Executive Officer of Anthem, Inc., a Fortune 29 company and the nation’s leading health benefits provider. He also served for more than 25 years as CEO for several major health systems, most recently Trinity Health, a 22-state integrated health care delivery system. Previously, he was President & CEO of Centura Health, Colorado’s largest health system, and formerly served as Division President for Hospital Corporation of America. Mr. Swedish has been extensively recognized for his leadership in the healthcare field. For 12 years in a row, Modern Healthcare named him one of the 100 Most Influential People in Healthcare, ranking in the top 20 of the health sector’s most senior-level executives, high-level government administrators, elected officials, academics, and thought-leaders for five consecutive years. In 2016, Mr. Swedish was one of five health care leaders named to Crain Communications’ Top 100 Innovators list. He serves on the board of directors for IBM Corporation, CDW, Mesoblast Limited (chairman), and Centrexion Therapeutics. Also, he has served as chairman and is currently a member of Duke University’s Fuqua School of Business Board of Visitors. Previously, Mr. Swedish served as board chairman of America’s Health Insurance Plans (AHIP), and chairman of the board, Catholic Health Association, a 600-hospital member organization. Mr. Swedish received his bachelor’s degree from the University of North Carolina at Charlotte and his master’s (MHA) degree in health administration from Duke University.

Chris Walsh Accelus CEO

Chris Walsh

Chris Walsh has served as the Chief Executive Officer and Co-Founder, and as a Director, of Accelus since 2016. From 2004 to 2013, Mr. Walsh distributed NuVasive for the state of Florida. Additionally, Mr. Walsh worked at Stryker Corporation as a Sales Manager from 1997 to 2004. Mr. Walsh holds a B.A. from the University of Florida.

Nathan Ward

Nathan Ward has served as a director of Accelus since 2016. Mr. Ward is a Managing Partner and Co-Founder of Palm Beach Capital, where his primary responsibilities include sourcing, structuring, and negotiating investment transactions. Post-acquisition, he works with portfolio companies on various operational and financial matters including add-on acquisitions, financings, expansion and growth initiatives, risk management, and strategic direction. Nate is a member of PBCP’s Investment Committee and has served on the Board of Directors of more than fifteen former and current Palm Beach Capital portfolio companies. He has led investments for the firm in a variety of industries including healthcare, business process outsourcers, aerospace, consumer products, logistics, and business-to-business services. Nate enjoys investing in and building businesses with his management teams. Prior to founding Palm Beach Capital, Nate started his career as a corporate lender at Bank of America in Virginia and then as VP of Mergers and Acquisitions at Workflow Management in Florida. Nate holds an undergraduate Finance degree from James Madison University and a M.B.A. from the University of Richmond.

Steven Whitlock

Steven Whitlock has served as a director of Accelus since 2022. Mr. Whitlock has over 30 years of experience in the orthopedic industry, and has served as the Managing Director of Spindletop Capital Management LLC since 2011 and as an officer of Spindletop Health Acquisition Corp., a newly formed SPAC, since 2021. Mr. Whitlock co-founded LDR Spine USA in 2004, where he served as the President and Chief Executive Officer from 2004 to 2006 and as the Vice President of Clinical Study Relations until 2008. Additionally, Mr. Whitlock served on the board of directors of LDR Spine USA from 2004 to 2010. Mr. Whitlock also co-founded Path4 Ventures in 2004 and served as an Operating Venture Partner with PTV Sciences from 2008 to 2011. During his time with Path4 Ventures, Mr. Whitlock co-founded Spinal Restoration Inc. in 2004 and served on the board of directors from 2004 to 2014. Mr. Whitlock also held board observer rights with Ortho Kinematics Inc. from 2009 to 2018. Mr. Whitlock began his career with Centerpulse Orthopedics (formerly Intermedics and Sulzer Orthopedics) in 1990 where he held various executive management roles in Global Research and Development, New Business Development, and Global Products in the areas of total joints, sports medicine, trauma, and orthobiologics. Mr. Whitlock has also served as the Owner and President of Straightway Ventures LLC since 2009, where he has held various roles as a Management Consultant for Molecular Matrix Inc. from 2018 to 2019, Bioventus LLC from 2019 to 2020, Integrity Implants Inc. from 2020 to 2021, and TruCell LLC from 2021 to present. Mr. Whitlock holds a B.S. in Mechanical Engineering from Texas A&M University and an M.B.A. from Embry–Riddle Aeronautical University.

Lisa P. Young

Lisa P. Young has served as a director of Accelus since 2022. Ms. Young also presently serves as the Chair of Accelus’s Audit and Finance Committee. Ms. Young worked at Ernst & Young (EY) for 36 years where she served in a number of leadership roles, most recently serving as a Senior Global Client Service Partner until her retirement in 2021. Ms. Young serves on the board of directors of Textainer Group Holdings, an NYSE registrant, where she also serves on the audit and risk committee and the compensation committee. Ms. Young serves as the Vice President of the Board of Trustees for the Columbus Museum of Art, the Treasurer of the Board of Directors of the Dallas Black Dance Theatre, and a member of the Texas Tech University Rawls College of Business Advisory Council. Previously, Ms. Young served as the Treasurer of the Board of Trustees for the Columbus School for Girls, on the Accounting Advisory Board for Fisher College of Business at The Ohio State University, and on EY’s Americas Advisory Council. Ms. Young holds a B.B.A. in Finance & Accounting from Texas Tech University and is a certified public accountant.